Corline Biomedical Stock

Corline Biomedical ROE

The Return on Equity (ROE) of Corline Biomedical (CLBIO.ST) as of Aug 9, 2026 is -15.69 %. In the previous year, Return on Equity (ROE) was -26.69 % — a change of -41.19% (higher).

ROE

-15.69 %

YoY

-41.19%

Last updated:

In 2026, Corline Biomedical's return on equity (ROE) was -15.69 %, a -41.19% increase from the -26.69 % ROE in the previous year.

Access this data via the Eulerpool API
Get Free API Key

Corline Biomedical Stock analysis

What does Corline Biomedical do? Corline Biomedical is one of the most popular companies on Eulerpool.

ROE Details

Decoding Corline Biomedical's Return on Equity (ROE)

Corline Biomedical's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Corline Biomedical's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Corline Biomedical's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Corline Biomedical’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Corline Biomedical stock

Return on Equity (ROE) of Corline Biomedical is -15.69 % in 2026.

Return on Equity (ROE) of Corline Biomedical changed from -26.69 % to -15.69 %, representing a -41.19% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Equity (ROE) Corline Biomedical since 2006 – with annual values, charts, and detailed analysis.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Equity (ROE)'s Corline Biomedical with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Equity (ROE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Equity (ROE).

Access this data via the Eulerpool API
Get Free API Key

Profitability — Corline Biomedical

ROEROAROCEROICAsset TurnoverInventory TurnoverReceivables TurnoverDays Sales OutstandingDays Inventory OutstandingDays Payable OutstandingCash Conversion CycleCROICGross Profit/AssetsFixed Asset TurnoverEquity TurnoverWorking Capital TurnoverPayables TurnoverCapital IntensityReceivables/RevenueInventory/RevenueEBIT/Assets

All Key Metrics — Corline Biomedical